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Abstract
Objectives: Few studies describe the impact of antimicrobial stewardship programs (ASPs) on recognizing and
preventing diagnostic errors. Handshake stewardship
(HS-ASP) is a novel ASP model that prospectively reviews
hospital-wide antimicrobial usage with recommendations
made in person to treatment teams. The purpose of this
study was to determine if HS-ASP could identify and
intervene on potential diagnostic errors for children hospitalized at a quaternary care children’s hospital.
Methods: Previously self-identified “Great Catch” (GC)
interventions by the Children’s Hospital Colorado HS-ASP
team from 10/2014 through 5/2018 were retrospectively
reviewed. Each GC was categorized based on the types of
recommendations from HS-ASP, including if any diagnostic recommendations were made to the treatment team.
Each GC was independently scored using the “Safer Dx
Instrument” to determine presence of diagnostic error
based on a previously determined cut-off score of ≤1.50.
Interrater reliability for the instrument was measured using
a randomized subset of one third of GCs.
Results: During the study period, there were 162 GC
interventions. Of these, 65 (40%) included diagnostic
recommendations by HS-ASP and 19 (12%) had a Safer Dx
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Score of ≤1.50, (Κ=0.44; moderate agreement). Of those GCs
associated with diagnostic errors, the HS-ASP team made a
diagnostic recommendation to the primary treatment team
95% of the time.
Conclusions: Handshake stewardship has the potential to
identify and intervene on diagnostic errors for hospitalized
children.
Keywords: antimicrobial stewardship; diagnostic error;
patient safety; pediatrics.

Introduction
Diagnostic errors occur frequently and often go unrecognized unless they harm patients via delayed, incorrect, or
missed diagnoses [1, 2]. In the US, 35–51% of pediatricians
report making a diagnostic error at least monthly and 82%
report ever making a diagnostic error that harmed a patient
[3–5]. In addition, infections are one of the most commonly
identiﬁed disease processes associated with diagnostic
errors [6]. Developing systems to identify and intervene on
diagnostic errors in real time could signiﬁcantly improve
patient safety and clinical care [7–10].
Antimicrobial stewardship programs (ASPs) identify
and intervene on a wide variety of patient safety incidents
related to antimicrobial usage. ASPs routinely correct
inappropriate antimicrobial choice or dosage, prevent use
of unnecessary antimicrobials, decrease adverse drug
events, and develop clinical pathways that standardize
patient care. Handshake stewardship (HS-ASP) is a novel
and highly successful antimicrobial stewardship model
developed at Children’s Hospital Colorado (CHCO) and
implemented in October 2013 [11–13]. Under the HS-ASP
model, a physician and pharmacist review relevant clinical data in the electronic health record (EHR) for all
hospitalized patients receiving any antimicrobial at 24
and 72 h after starting treatment. Recommendations are
then communicated in person to medical and surgical
teams Monday through Friday.
By design, HS-ASP requires a compressed “second look”
of the presenting symptoms, laboratory and radiographic
results, and documented medical decision-making for
This work is licensed under the Creative Commons Attribution 4.0
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hospitalized patients. HS-ASP, thus, has the potential
to intervene on a wide range of potential patient safety
concerns, including possible diagnostic errors. The purpose of this study was to retrospectively determine whether
HS-ASP interventions identify diagnostic errors among
hospitalized children, thereby offering a valuable contribution to the diagnostic process.

Materials and methods
The HS-ASP model was implemented at CHCO in October 2013. Starting in October 2014, the CHCO HS-ASP team began prospectively
labeling some specific interventions as “Great Catches” (GCs). Select
HS-ASP interventions were deemed GCs by the individual steward if
the intervention “notably changed or had the potential to change the
trajectory of patient care” (Table 1). Patient EHR documentation for all
GCs from October 2014 through May 2018 were retrospectively
reviewed. Based on HS-ASP recommendations, each GC was assigned

one or more intervention categories including therapeutic and diagnostic interventions related to individual patient care, as well as
epidemiologic interventions that identiﬁed an important issue beyond
the individual patient receiving the intervention. Epidemiologic interventions identiﬁed potential hospital-wide concerns such as
emerging outbreaks within the hospital, as well as patients with highly
contagious diseases requiring speciﬁc isolation precautions or antimicrobial prophylaxis for close contacts (Table 2).
Each intervention was scored by a non-ASP pediatric infectious
disease physician (Reviewer#1, JS) using the previously validated
“Safer Dx Instrument” [7, 14]. The Safer Dx Instrument (Table 3) is an
11-item rating survey designed to retrospectively determine whether
a given clinical scenario involved diagnostic error deﬁned as “missed
opportunities to make a correct or timely diagnosis based on the
available evidence, regardless of patient harm” [7]. When ﬁrst
describing The Safer Dx instrument, Al-Mutairi et al. used multivariate logistic regression to develop an equation to calculate the
overall “error score” of any given clinical scenario using the Safer
Dx Instrument. The ﬁnal equation they described was: Error
Score=0.395 + (∑Question 1, 2, 5–7, 9, 10 × 0.03) + (∑Question 3,
8 × 0.003) + (Question 4 × −0.005) + (Question 11 × 0.05) [7]. Using
this equation, the lowest possible error score is 0.656 and the highest

Table : Representative great catch examples.
Description of case

ASP recommendation

Impact on care

Twelve-year-old with headache and fever, mild CSF ASP suggested evaluation for
parameningeal infection focus.
pleocytosis, signiﬁcantly elevated CRP. CSF PCR
studies negative. Diagnosed with “viral meningitis.”
Two-month-old with GBS bacteremia and vaginal
ecchymosis. Treated for late-onset GBS sepsis and
team planning to consult child protection team for
sexual abuse evaluation due to “vaginal bruising.”

MRI brain identiﬁed cavernous sinus thrombosis
with extending purulence and sphenoid sinusitis.
Safer Dx error score: .

Team held off on child protection team consultation
ASP educated team about known
which prevented family stress, negative impact on
phenomenon of violaceous skin
lesions in patients with GBS sepsis. therapeutic relationship, and unnecessary use of
resources.
Safer Dx error score: .

Eight-month-old with CSF pleocytosis felt to be “viral ASP suggested rethinking diagmeningitis,” though signiﬁcantly elevated ESR/CRP. nosis and formal infectious diseases consult based on elevated
inﬂammatory markers.

ID consulted, based on history and exam recommended echocardiogram. Found to have signiﬁcant
coronary artery aneurysms. Patient diagnosed and
treated for Kawasaki disease.
Safer Dx error score: .

One-month-old with fever. CSF with one WBC, also ASP recommended parechovirus
found to have mild thrombocytopenia and elevated PCR testing on CSF.
transaminases. Admitted to NICU and started sepsis
rule out with ampicillin, acyclovir, and cefotaxime.

Parechovirus PCR was positive, antimicrobials were
discontinued, and patient was discharged.
Safer Dx error score: .

Table : Great catch recommendation categories.
Therapeutic
–
–
–
–
–
–
–

Diagnostic

Medication administration error
–
Empiric therapy escalation/de-escalation –
Bug-drug mismatch
–
Inappropriate dose/duration
Potential adverse effect
Prevent/shorten hospital admission
Preventative care or immunization

Epidemiologic

Consider alternative diagnosis
–
Additional testing needed
Microbiology result interpretation –
–
–

Need for prophylaxis for close contacts of
contagious disease
Epidemiology investigation/potential
outbreak
Cases representative of variability in care that
would beneﬁt from clinical pathways
Change to patient isolation/precautions
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is 1.961. The lower the error score, the stronger the association with
diagnostic error. Al-Mutairi et al. offer the example of using an error
score ≤1.50 to designate presence of a diagnostic error; we used this
same cutoff of an error score ≤1.50 to identify GCs associated with a
diagnostic error [7]. A 12th question was also included and stated: “In
conclusion, based on all the above questions, the episode of care
under review had a diagnostic error.” The results of reviewers’ answers to question 12 were included as a dichotomized variable for
whether the reviewer felt the case included a diagnostic error overall.
To measure interrater reliability (IRR) of the Safer Dx scores, a
second non-ASP pediatric infectious disease physician (Reviewer #2,
JB) reviewed a random sample of 55 of 162 (34%) GCs and was blinded
to the first reviewer’s scores. The need for 55 chart reviews was
calculated based on previously described nomograms for kappa
coefficient calculation [15]. Prior to completing these 55 GC reviews,
ﬁve non-randomized GCs were reviewed by both reviewers together
to calibrate scoring using the Safer Dx instrument and develop a
shared mental model as recommended [16]. Results for the ﬁnal Safer
Dx scores from both reviewers and the dichotomized item 12 (“yes/no
this case involved a diagnostic error”) were compared; a kappa

Table : The safer Dx instrument [].
Rate the following items for the episode of care under review:
( strongly agree;  strongly disagree)
(1) The history that was documented at the patient–provider
encounter was suggestive of an alternate diagnosis, which was
not considered in the assessment.
(2) The physical exam documented at the patient–provider
encounter was suggestive of an alternate diagnosis, which was
not considered in the assessment.
(3) Diagnostic testing data (laboratory, radiology, pathology or
other results) associated with the patient–provider encounter
were suggestive of an alternate diagnosis, which was not
considered in the initial assessment.
(4) The diagnostic process at the initial assessment was affected by
incomplete or incorrect clinical information given to the care
team by the patient or their primary caregiver.
(5) The clinical information (i.e., history, physical exam or diagnostic data) present at the initial assessment should have
prompted additional diagnostic evaluation through tests or
consults.
(6) The initial assessment at an earlier visit was appropriate, given
the patient’s medical history and clinical presentation.
(7) Alarm symptoms or “red ﬂags” (i.e., features in the clinical
presentation that are considered to predict serious disease)
were not acted upon at an earlier assessment.
(8) Diagnostic data (laboratory, radiology, pathology or other results) available or documented at the initial assessment were
misinterpreted in relation to the subsequent ﬁnal diagnosis.
(9) The differential diagnosis documented at the initial assessment
included the subsequent ﬁnal diagnosis.
(10) The ﬁnal diagnosis was an evolution of the initial presumed
diagnosis.
(11) The clinical presentation was not typical of the ﬁnal diagnosis.
Safer Dx error score=. + ( ∑Item , , –, , ×.) + ( ∑Item
, ×.) + (item ×−.) + (item ×.).

coefﬁcient and 95% conﬁdence intervals (CI) were calculated for
both measures.
Descriptive statistics were presented for patient demographic
data and intervention data. A χ2-test was performed to compare the
percentage of diagnostic intervention recommendations for patients
with a diagnostic error to those without a diagnostic error. This project
was approved by the CHCO Organizational Research Risk and Quality
Improvement Review Panel.

Results
From October 1, 2014 through May 31, 2018, there were
85296 inpatient admissions to CHCO, of which 35576
(42%) received an antimicrobial during hospitalization.
The HS-ASP team formally intervened on 6735 (19%)
antimicrobial-associated admissions during the study
period. Among HS-ASP interventions, 174 (2.6%) were
labeled by HS-ASP stewards as GCs. After retrospective
review by Reviewer #1, 12 GCs were excluded for not
meeting the deﬁnition of GC, chart duplication, or inadequate documentation of HS-ASP intervention, leaving
162 GCs for analysis (Table 4). Nearly half of the GCs (48%)
involved interventions with the general medical teams or
surgical services, and one third (35%) occurred in an
intensive care setting.
Many of the GCs were assigned more than one intervention category (therapeutic, diagnostic, and epidemiologic). Most GCs involved therapeutic interventions only
Table : Patient and intervention overview for great catches
(n=).
Number of patients, %
Patient demographics
Median age, years
Male
Treatment team
General medical teams
Surgical services
NICU
PICU
Heme/Onc
CICU/CPCU
Emergency department
Outpatient primary care
Intervention overview
Therapeutic interventions
Diagnostic interventions
Epidemiologic interventions
Intervention(s) “accepted” by team
ID consultation overview
ID consult recommended
ID consult within three days of intervention
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(91/162, 56%), while 12% (19/162) provided diagnostic
recommendations only; 28% of GCs (46/162) included both
therapeutic and diagnostic recommendations to primary
teams (Table 4). A small group of interventions (11/162, 7%)
had larger epidemiologic implications (Table 2, 4). Most
HS-ASP recommendations were implemented by the
treatment teams (158/162, 98%). In addition to these therapeutic, diagnostic, and epidemiologic recommendations,
the HS-ASP team also recommended obtaining formal infectious disease (ID) consultation in 39/162 (24%) of GC
interventions and, when ID consultation was recommended, the team consulted ID 69% of the time (Table 4).
After primary review, 19 (12%) GC cases had a calculated overall Safer Dx Score of ≤1.50, indicating presence of
diagnostic error (Table 5). Demographic information,
including patient age and treatment team, was similar for
GCs with and without diagnostic errors. Of those GCs
associated with a diagnostic error, 95% included at least
one diagnostic recommendation from the HS-ASP team,
whereas among GCs without diagnostic error (Safer Dx
Score >1.50), only 33% had a diagnostic recommendation
from HS-ASP, p<0.001 (Table 5). Of those GCs with Safer Dx
Score ≤1.50, 17 (89%) had an answer of “yes” for question
12. Among patients who met criteria for a diagnostic error,
treatment teams accepted HS-ASP recommendations in
18/19 (95%) with a Safer Dx Score ≤1.50 and 16/17 (94%)
with an answer of “yes” for question 12. There were no GCs
with a calculated Safer Dx score >1.50 for which the
reviewer answered “yes” to question 12.
Of the 55 cases randomly selected to assess IRR,
Reviewer #1 scored 10 cases ≤1.50 and Reviewer #2 scored
15 cases ≤1.50. For dichotomized question 12, Reviewer #1
responded “yes the case involved a diagnostic error” for
9 cases, and Reviewer #2 responded “yes” for 16 cases
(Table 6). There was 80% agreement between the two
reviewers for both Safer Dx scores and dichotomized
question 12 (yes/no). The kappa coefﬁcient for IRR was 0.44

Table : Great catch diagnostic errors.
Number of patients, %
Safer Dx error score
≤.
.–.
≥.
Patients with diagnostic error, (safer Dx ≤.)
Yes to question 
No to question 
Diagnostic ASP intervention

/, 
/, 
/, 
/a, 
/, 
/, 

/ patients had both “Yes” to question  and safer Dx error
score >..
a

Table : Agreement for great catch scoring.
Reviewer scores for overall safer Dx score (n=)
Reviewer #

Reviewer #

≤.
>.

≤.

>.







Reviewer responses for question  (n=)
Reviewer #

Reviewer #

“Yes”
“No”

“Yes”

“No”







(95% CI 0.16–0.71) for the Safer Dx scores and 0.44 (95% CI
0.18–0.71) for the dichotomized question 12 (yes/no),
indicating moderate agreement.

Discussion
In this study of notable HS-ASP interventions, 12% of GCs
involved a diagnostic error using the previously validated
Safer Dx Instrument with moderate agreement between
two reviewers (K=0.44, agreement 80%). Nearly all GCs
associated with diagnostic error had a diagnostic recommendation made by the HS-ASP team suggesting an
opportunity to correct a misdiagnosis or identify a missed
diagnosis. Our ﬁndings indicate that, in addition to preventing a wide range of potential adverse events related to
antimicrobial use, the HS-ASP model may also identify and
intervene on diagnostic errors.
In the course of routine care, the diagnostic process
occurs longitudinally, with information provided in a
stepwise fashion. A patient arrives seeking an explanation
of their health problem, initial vital signs are recorded, a
history and physical exam are performed, and preliminary
diagnostic studies are obtained with results returning
at intervals frequently asynchronous with the patient
encounter [17]. During this process, a patient’s clinical
trajectory may evolve over time and the initial presentation
may not offer sufﬁcient distinguishing features to make the
correct diagnosis [18]. This cumulative and sequential
information gathering inherent to the diagnostic process
can inﬂuence the ﬁnal diagnosis through well-described
heuristic failures like premature closure, anchoring, or
conﬁrmation bias [19–21]. By design, HS-ASP may interrupt these cognitive miscues by offering a “compressed
second look” of objective and subjective data for patients
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at two checkpoints (24 and 72 h after starting an antimicrobial). Through individual, directed chart reviews at
these time points, the HS-ASP steward obtains a “bird’seye view” of the clinical data for a given patient, including
the evolution of the disease over a brief time period and
can offer a unique perspective on the diagnostic process.
This perspective is communicated by in-person conversation with frontline providers allowing for diagnostic
error recognition and intervention.
Decreased face-to-face communication between providers contributes to diagnostic errors as providers
increasingly practice in diagnostic isolation. As described
by Graber et al., “The EHR has become the de facto norm for
communication in health care, leading each member of the
team to work independently, in their own silo … the faceto-face communication that was once the norm in the
course of a diagnostic evaluation has been replaced by
opaque orders and formulaic reports, both of which lack
the rich detail that was inherent when providers talked
with each other” [22]. In-person communication with
frontline providers is an important and distinguishing
feature of the HS-ASP model [11–13, 23]. Face-to-face
communication by HS-ASP allows for nuanced and reciprocal conversations that may promote recognition and
intervention before diagnostic errors harm patients.
Improving teamwork in the diagnostic process is one
strategy recommended by the National Academy of
Medicine to prevent errors [17]. A “collective intelligence
approach” was recently shown to improve diagnostic
accuracy compared to individual physicians, and facilitating access to second opinions has been identiﬁed as a
means to prevent diagnostic error [24–26]. In an effort to
expedite teamwork and improve diagnostic accuracy,
several institutions have implemented so-called “diagnostic management teams (DMTs)” consisting of expert
diagnosticians (pathologists, radiologists, microbiologists,
etc.) that proactively review cases and offer guidance for a
tailored diagnostic approach for individual patients [22, 27,
28]. These teams have demonstrated early promise for
improving diagnostic accuracy and decreasing errors. Our
ﬁndings support the claim that HS-ASP may function as a
contributor to such an “expanded diagnostic team” [22].
HS-ASP reviews charts only for those patients
receiving antimicrobials, and there are likely patients
with diagnostic errors neither identified nor reviewed by
HS-ASP. However, 50–65% of all children admitted to a
pediatric hospital receive antimicrobials, and during this
study period, HS-ASP intervened on 19% of all admissions
in which antimicrobials were prescribed [13, 29]. This
suggests that HS-ASP represents a signiﬁcant opportunity
to mitigate harm from diagnostic errors for many patients
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across multiple clinical units. In addition to these individual patient-level diagnostic errors, our study also
suggests that HS-ASP may play a role in larger hospitalwide diagnostic errors. For example, several of the GCs
intervened on epidemiologic concerns that had been unrecognized by providers. One such example involved
several concurrent cases of Enterobacter cloacae infection
in the CHCO neonatal intensive care unit that were not
recognized as an outbreak until the HS-ASP team noted
these similar infections in a short time period. HS-ASP has
a longitudinal presence on every inpatient unit at CHCO,
offering a macroscopic and real-time assessment of active
hospital-wide infectious concerns.
There are several limitations to our study. Our study
subjectively relies on retrospective review of EHR documentation which limits the ability to evaluate a provider’s
reasoning during the diagnostic process; for example,
further work-up was planned but enacting such evaluation
required the results of initial testing. Prior studies have
identified low interrater reliability when determining presence of diagnostic error in retrospectively reviewed cases
[8, 16, 30–32]. Our use of a validated scoring system and two
blinded reviewers attempted to offset this inherent subjectivity. In addition, since this project ended, a new version of
the Safer Dx instrument has been published, and our ﬁndings may have been limited by using the original Safer Dx
instrument instead of the improved version of the questionnaire [16]. Lastly, the HS-ASP model was developed at
CHCO by providers dedicated to its success. Therefore, our
results of HS-ASP as a model to recognize and prevent
diagnostic errors may not be generalizable to other institutions, even those with a similar HS-ASP format. Future
prospective evaluations are needed to evaluate the HS-ASP
model to study whether it can serve a valuable role on the
“diagnostic team” and what, if any, unintended consequences arise from HS-ASP diagnostic recommendations.
Despite these limitations, our findings demonstrate
potential for HS-ASP to identify and intervene on diagnostic errors among hospitalized children. As argued by
Singh, health care organizations should “choose at least
one diagnostic error detection strategy to augment their
existing safety and/or risk management programs” [18].
Our ﬁndings show that HS-ASP can serve as a model to
intervene proactively on diagnostic errors and could be one
such strategy employed by health care organizations to
make a signiﬁcant contribution to improve care.
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